Does Prophylactic Coronary Artery Revascularization for High Risk Patients Reduce Long-Term Risk of Mortality

This study has been completed.

First Received: March 19, 2002 Last Updated: April 25, 2008 History of Changes

Sponsored by:	Department of Veterans Affairs
Information provided by:	Department of Veterans Affairs
ClinicalTrials.gov Identifier:	NCT00032370

Purpose

Although a number of sophisticated diagnostic tests have been shown to be helpful in identifying patients at high risk for perioperative cardiac complications, no study has addressed the most important question: Should prophylactic coronary revascularization be performed prior to elective vascular surgery? This study is designed to answer this question.

Condition	Intervention	Phase
Cardiovascular Disease	Procedure: Vascular surgery with best medical treatment Procedure: Coronary artery bypass grafting (CABG) Procedure: Percutaneous transluminal coronary angioplasty (PTCA)	Phase III

Study Type:	Interventional
Study Design:	Treatment, Randomized
Official Title:	THE CORONARY ARTERY REVASCULARIZATION PROPHYLAXIS (CARP) TRIAL

Resource links provided by NLM:

MedlinePlus related topics: Surgery

U.S. FDA Resources

Further study details as provided by Department of Veterans Affairs:

Estimated Enrollment:	560
Study Start Date:	August 1997
Estimated Study Completion Date:	February 2004

Show Detailed Description

Eligibility

Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No

Criteria

High risk patients scheduled for elective vascular surgery

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00032370

Locations

United States, Arizona
Tucson VA Medical Center
Tucson, Arizona, United States, 85723
United States, Arkansas
Central AR Veterans HCS
Little Rock, Arkansas, United States, 72205-5484
United States, California
San Francisco VA Medical Center
San Francisco, California, United States, 94121
West LA VA Medical Center
West Los Angeles, California, United States, 90073
United States, Colorado
Denver VA Medical Center
Denver, Colorado, United States, 80220
United States, Florida
Gainesville VA Medical Center
Gainesville, Florida, United States, 32608-1197
Tampa VA Medical Center
Tampa, Florida, United States, 33612
United States, Georgia
Atlanta VA Medical Center
Atlanta, Georgia, United States, 30033
United States, Indiana
Indianapolis VA Medical Center
Indianapolis, Indiana, United States, 46202
United States, Minnesota
Minneapolis VA Medical Center
Minneapolis, Minnesota, United States, 55417
United States, New Mexico
Albuquerque VA Medical Center
Albuquerque, New Mexico, United States, 87108
United States, North Carolina
Durham VA Medical Center
Durham, North Carolina, United States, 27705
United States, Ohio
Cleveland VA Medical Center
Cleveland, Ohio, United States, 44106
United States, Oregon
Portland VA Medical Center
Portland, Oregon, United States, 97201
United States, Pennsylvania
VA Pittsburgh Health Care System
Pittsburgh, Pennsylvania, United States, 15240
United States, Texas
Dallas VA Medical Center
Dallas, Texas, United States, 75216
San Antonio VA Medical Center
San Antonio, Texas, United States, 78284
United States, Washington
Puget Sound Health Care System
Seattle, Washington, United States, 98108

Sponsors and Collaborators

Department of Veterans Affairs

More Information

No publications provided

Study ID Numbers:	411
Study First Received:	March 19, 2002
Last Updated:	April 25, 2008
ClinicalTrials.gov Identifier:	NCT00032370 History of Changes
Health Authority:	United States: Federal Government

Keywords provided by Department of Veterans Affairs:

Prophylactic coronary artery revascularization
myocardial infarction

Study placed in the following topic categories:

Infarction
Myocardial Infarction

Additional relevant MeSH terms:

Cardiovascular Diseases

ClinicalTrials.gov processed this record on July 02, 2009